Connexin 43-Enhanced Suicide Gene Therapy Using Herpesviral Vectors

This publication has 40 references indexed in Scilit:

• Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle
  The Journal of Gene Medicine, 1999
• In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy
  Gene Therapy, 1998
• Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
  Gene Therapy, 1998
• Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene
  Human Gene Therapy, 1997
• The “Bystander Effect”: Association of U-87 Cell Death with Ganciclovir-Mediated Apoptosis of Nearby Cells and Lack of Effect in Athymic Mice
  Human Gene Therapy, 1995
• Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.
  Proceedings of the National Academy of Sciences, 1994
• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
  Proceedings of the National Academy of Sciences, 1994
• In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy
  Human Gene Therapy, 1993
• Thymidine kinase-mediated killing of rat brain tumors
  Journal of Neurosurgery, 1993
• Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.
  Proceedings of the National Academy of Sciences, 1993